Rs727479

endometrial cancer rs727479(A) odds ratio per allele of 1.08, 95% confidence interval of 1.02-1.14, and P = 0.009

Association analyses of CYP19 gene polymorphisms with height variation in a large sample of Caucasian nuclear families.

Polymorphisms of estrogen-biosynthesis genes CYP17 and CYP19 may influence age at menarche: a genetic association study in Caucasian females.

Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal women.

Haplotype analyses of CYP19A1 gene variants and breast cancer risk: results from the Shanghai Breast Cancer Study.

A single-nucleotide polymorphism in the aromatase gene is associated with the efficacy of the aromatase inhibitor letrozole in advanced breast carcinoma.

Association of genetic polymorphisms in CYP19A1 and blood levels of sex hormones among postmenopausal Chinese women.

Association of two common single-nucleotide polymorphisms in the CYP19A1 locus and ovarian cancer risk.

Coffee intake, variants in genes involved in caffeine metabolism, and the risk of epithelial ovarian cancer.

Polymorphisms in estrogen- and androgen-metabolizing genes and the risk of gastric cancer.

Genetic variation in CYP19A1 and risk of breast cancer and fibrocystic breast conditions among women in Shanghai, China.

Anastrozole Use in Early Stage Breast Cancer of Post-Menopausal Women.

A polymorphism at the 3'-UTR region of the aromatase gene defines a subgroup of postmenopausal breast cancer patients with poor response to neoadjuvant letrozole.


 * is_associated_with_disease::Endometrial cancer
 * is_associated_with_disease::Ovarian cancer
 * is_associated_with_disease::Prostate cancer
 * is_associated_with_disease::Breast carcinoma
 * is_associated_with_disease::Carcinoma